Company Profile

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE111.801.05 (+0.95 % )
PREV CLOSE (Rs.) 110.75
OPEN PRICE (Rs.) 109.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 60705
TODAY'S LOW / HIGH (Rs.)108.55 112.40
52 WK LOW / HIGH (Rs.) 48.7 218.7
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.23
TTM EPS (Rs.) 5.31
P/E Ratio 21.05
Book Value (Rs.) 37.02
Face Value (Rs.) 5
MCap (Rs. in Mn) 5602.52
Price/Earning (TTM) 13.36
Price/Sales (TTM) 1.38
Price/Book (MRQ) 3.02
PAT Margin (%) 4.50
ROCE (%) 10.87
Incorporation Year : 1960

Management Info :

Jasvantlal G Shah - Chairman - Managing Director

Registered Office :

Address : 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone : +91-22-66227575

Email : anuh@sk1932.com

Website : www.anuhpharma.com

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
08Jan01-08-2021$ Announcement under Regulation 30 (LODR)-Change in Directorate Announcement under Regulati
Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held today i.e. Friday, 8th January, 2021, inter-alia considered and approved the following agenda Items: 1.Appointment of Mr. Bipin N. Shah (DIN: 00083244) as a Non-Executive Director and Vice Chairman of the Company with effect from 08th January, 2021, whose period of office shall be liable to retire by rotation; 2.The relinquishment of position of Managing Director by Mr. Bipin N. Shah (DIN: 00083244) for the purpose of Board Restructuring; 3.The appointment and re-designation of Mr. Ritesh B. Shah and Mr. Vivek B. Shah as Joint Managing Directors from the position of Whole Time Directors & Chief Executive Officers for a period of 5 years w.e.f. 8th January, 2021 to 7th January, 2026.
Pursuant to the provisions of Regulation 30 read with Schedule..
08Jan01-08-2021$ Announcement under Regulation 30 (LODR)-Resignation of Managing Director Announcement under Regulati
We wish to inform you that Mr. Bipin N. Shah, Managing Director, relinquished the position of Managing Director of the Company with effect from the closing of business hours of Thursday, 7th January, 2021 for the purpose of Board Restructuring. However, he has been appointed as Non-Executive Director and Vice Chairman of the Company w.e.f. 8th January, 2021.
We wish to inform you that Mr. Bipin N. Shah, Managing Director..
08Jan01-08-2021$ Outcome Of Board Meeting Held On 08/01/2021 Outcome Of Board Meeting He
Please note at the Board Meeting held on 08/01/2021, the following items were considered and approved :1)1. Appointment of Mr. Bipin N. Shah as a Non-Executive Director and Vice Chairman of the Company with effect from 08th January, 2021 2) The relinquishment of position of Managing Director by Mr. Bipin N. Shah for the purpose of Board Restructuring 3) The appointment and re-designation of Mr. Ritesh B. Shah and Mr. Vivek B. Shah as Joint Managing Directors from the position of Whole Time Directors & Chief Executive Officers w.e.f. 8th January, 2021 .
Please note at the Board Meeting held on 08/01/2021, the follow..
08Jan01-08-2021$ Outcome Of Board Meeting Held On 08/01/2021 Outcome Of Board Meeting He
Please note at the Board Meeting held on 08/01/2021, the following items were considered and approved :1)1. Appointment of Mr. Bipin N. Shah as a Non-Executive Director and Vice Chairman of the Company with effect from 08th January, 2021 2) The relinquishment of position of Managing Director by Mr. Bipin N. Shah for the purpose of Board Restructuring 3) The appointment and re-designation of Mr. Ritesh B. Shah and Mr. Vivek B. Shah as Joint Managing Directors from the position of Whole Time Directors & Chief Executive Officers w.e.f. 8th January, 2021 .
Please note at the Board Meeting held on 08/01/2021, the follow..
08Jan01-08-2021$Appointment of Chairman Appointment of Chairman
inter alia, approved 1. Appointment of Mr. Bipin N. Shah as a Non-Executive Director and Vice Chairman of the Company with effect from 08th January, 2021 2) The relinquishment of position of Managing Director by Mr. Bipin N. Shah for the purpose of Board Restructuring 3) The appointment and re-designation of Mr. Ritesh B. Shah and Mr. Vivek B. Shah as Joint Managing Directors from the position of Whole Time Directors & Chief Executive Officers w.e.f. 8th January, 2021 .
inter alia, approved 1. Appointment of Mr. Bipin N. Shah as a N..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit41.7999999999999143.05
Gross Profit 46.9899999999999 191.55
Operating Profit 89.1999999999999269.8
Net Sales 983.33069.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 8268.85 (1.40%)
M.Cap ( in Cr)
19043.68
Abbott India (BSE)
 14396.65 (0.34%)
M.Cap ( in Cr)
30591.88
Orchid Pharma (BSE)
 885.15 (5.00%)
M.Cap ( in Cr)
3612.86
Alembic Pharma (BSE)
 919.15 (2.38%)
M.Cap ( in Cr)
18067.10
Natural Capsules (BSE)
 117.40 (19.98%)
M.Cap ( in Cr)
73.17
Shareholding Pattern More
PROMOTERS 70.46 %
NON-INSTITUTION 29.54 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Nippon India Pharma Fun...2.44
F & O Quotes